(Press-News.org) Researchers at University of Galway have taken a significant step forward in the management of gestational diabetes mellitus after a clinical trial involving pregnant women provided new hope for expectant mothers suffering the condition.
The findings from the trial are being published in JAMA: the Journal of American Medical Association.
Gestational diabetes is a global health issue affecting almost 3 million pregnant women worldwide every year. It is a condition characterised by elevated blood sugar levels during pregnancy, posing increased health risks for both mothers and their babies.
Professor Fidelma Dunne, Professor of Medicine at University of Galway and Consultant Endocrinologist at Saolta University Health Care Group, managed the EMERGE, randomised, placebo-controlled trial, involving more than 500 pregnant women.
Women assigned to metformin were 25% less likely to need insulin, and when insulin was necessary, it was started later in the pregnancy. Metformin is used routinely in the treatment of Type 2 Diabetes and has been widely available for over 60 years.
Fasting and post-meal sugar values in the mother were significantly lower in the metformin exposed group at weeks 32 and 38.
Women receiving metformin gained less weight throughout the trial and maintained this weight difference at the 12-week post-delivery visit.
Importantly, delivery occurred at the same mean gestational age (39.1 weeks) in both groups. There was no evidence of any increase in preterm birth (defined as birth before 37 weeks) among those who received metformin.
Infants born to mothers who received metformin weighed, on average, 113g less at birth, with significantly fewer infants classified as large at birth, or weighing over 4kg (8lbs 8ounces).
While there was a slight reduction in infant length (0.7cm), there were no other significant differences in baby measurements.
There were slightly more babies who were small at birth but this did not reach statistical significance.
The study also revealed no differences in adverse neonatal outcomes, including the need for intensive care treatment for new-borns, respiratory support, jaundice, congenital anomalies, birth injuries or low sugar levels.
Additionally there were no variations in rates of labour induction, caesarean delivery, maternal haemorrhage, infection or blood pressure issues during or after birth.
Professor Fidelma Dunne presented the results (on Tuesday October 3, 2023) at the 59th Annual Meeting of the European Association for the Study of Diabetes in Hamburg, Germany.
Professor Dunne said: “While there is convincing evidence that improved sugar control is associated with improved pregnancy outcomes, there was uncertainty about the optimal management approach following a diagnosis of gestational diabetes.
“In our pursuit of a safe and effective treatment option we explored an alternative approach – administering the drug metformin. A previous trial compared metformin to insulin and found it to be effective, yet concerns remained, especially regarding preterm birth and infant size.”
To address concerns comprehensively, the team at University of Galway conducted a ground-breaking placebo-controlled-trial, filling a critical gap in the gestational diabetes treatment landscape.
535 pregnant women took part, with 268 receiving metformin and 267 a placebo.
98% of women remained in the trial until delivery, with 88% completing the 12-week post-delivery follow up assessment.
Only 4.9% of women discontinued medication due to side effects, highlighting the safety of the interventions.
Professor Dunne said: “Traditionally, gestational diabetes has been managed initially through dietary advice and exercise, with insulin introduced if sugar levels remain sub optimal. While effective in reducing poor pregnancy outcomes, insulin use is associated with challenges, including low sugars in both the mother and infant which may require neonatal intensive care, excess weight gain for mothers, and higher caesarean birth rates.
“For mothers with gestational diabetes, they are also at greater risk of high blood pressure and preeclampsia.
“Babies born to mothers with gestational diabetes face their own set of risks, such as excessive weight at birth, birth injuries, respiratory difficulties and low sugar levels after delivery potentially requiring admission to neonatal intensive care. Gestational diabetes also increases the lifetime risk of diabetes for these mothers and their children. In addition mothers have an elevated lifetime risk of cardiovascular disease. Furthermore, low and middle-income countries bear a significant burden of gestational diabetes cases.”
Professor Dunne added: “The results from the EMERGE study are a significant step forward for women with gestational diabetes. Metformin has emerged as an effective alternative for managing gestational diabetes, offering new hope for expectant mothers and healthcare providers worldwide.”
Pregnant women offered new hope for safe and effective gestational diabetes treatment
New study from University of Galway alleviates concerns over metformin drug for mothers and babies
ELSE PRESS RELEASES FROM THIS DATE:
Early metformin in gestational diabetes
About The Study: In this randomized clinical trial, early treatment with metformin was not superior to placebo for the composite primary outcome of insulin initiation or a fasting glucose level of 5.1 mmol/L or greater at gestation weeks 32 or 38. Prespecified secondary outcome data support further investigation of metformin in larger clinical trials. Authors: Fidelma Dunne, Ph.D., of the University of Galway in Galway, Ireland, is the corresponding author. To access the embargoed study: Visit our For The Media website ...
Tirzepatide vs insulin lispro added to basal insulin in type 2 diabetes
About The Study: In people with inadequately controlled type 2 diabetes treated with basal insulin in this randomized clinical trial with 1,428 participants, weekly tirzepatide compared with prandial insulin as an additional treatment with insulin glargine demonstrated reductions in HbA1c and body weight with less hypoglycemia. Authors: Julio Rosenstock, M.D., of Velocity Clinical Research at Medical City in Dallas, is the corresponding author. To access the embargoed study: Visit our For The Media ...
New biobanking partnership safeguards the genetic diversity of America’s endangered species
San Francisco, CA - The nonprofit Revive & Restore announces a groundbreaking new initiative to biobank U.S. endangered species, in partnership with the U.S. Fish & Wildlife Service. This multi-institution collaboration is the first systematic biobanking pipeline for U.S. threatened and endangered species. The initiative will protect genetic diversity for current and future recovery efforts. "This is about creating a legacy of America’s natural history before it is lost and provides an important resource to enhance species recovery efforts now and in the future,” said Ryan Phelan, Executive Director of Revive & ...
Eating disorders increased during pandemic in female adolescents and adults
Emergency department (ED) visits and hospital admissions for eating disorders increased during the COVID-19 pandemic in adolescents aged 10–17 years, as did ED visits among young adults and older adults, according to new research published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221318. Using ICES data, researchers compared observed and expected rates of ED visits and hospitalizations for eating disorders before (Jan. 1, 2017, to Feb. 29, 2020) and during the pandemic (Mar. 1, 2020, to Aug. 31, 2022) in adolescents (10–17 years), young adults (18–26 years), adults (27–40 years) ...
Improved mangrove conservation could yield cash, carbon, coastal benefits
A shift in the way we think about the benefits mangroves provide to coastal regions could yield significant economic and biodiversity gains and protect millions from flooding, research has revealed. The University of Queensland-led study shows current conservation efforts typically target biodiversity protection whilst minimising conflict with economic interests, while failing to consider the huge benefits provided by ecosystems. Alvise Dabalà, now at the University of the Azores and whose Masters project at UQ formed the basis of this study, said human activities, such as deforestation and coastal development have led to extensive ...
Brain biometrics help identify sports concussions
Novel brain biometrics could help inform whether an athlete is ready to return to play following a concussion, according to new research from the University of South Australia. Conducted in partnership with the University of California San Francisco (UCFC), researchers found that changes in micromovements of the brain – termed ‘headpulses’ – could detect the lasting impacts of a concussion. Using a custom-designed headset* to evaluate headpulse biometrics among 101 amateur male and female Australian ...
Study uncovers reasons Americans did not get booster vaccines
The paper, “Understanding low bivalent COVID-19 booster uptake among US adults,” was published in the journal Vaccine. “Our results indicate that we have a lot more work to do in terms of educating the public and health care providers about the importance of staying up to date on COVID-19 boosters,” said first author Elizabeth Jacobs, PhD, professor of epidemiology at the Zuckerman College of Public Health, who led the research with associate professor of epidemiology Kristen Pogreba-Brown, PhD, MPH. Nearly 40% of survey participants reported they did not get a booster shot because ...
Texas engineers land semiconductor grants through CHIPS Act-backed NSF program
A pair of Cockrell School research teams are part of a massive semiconductor grant program from the National Science Foundation that includes funds from industry leaders and the federal CHIPS Act. The projects are part of the NSF Future of Semiconductors (FuSe) program through a public-private partnership between NSF and four major tech companies: Ericsson, IBM, Intel and Samsung. FuSe aims to enable rapid progress in new semiconductor technologies and manufacturing as well as workforce development. Altogether, the program will support 24 research and ...
Gut bacteria found in wild wolves may be key to improving domestic dogs’ health
BEND, Ore. – Gut microbes found in wild wolves may be the key to alleviating a debilitating gastrointestinal condition common to domestic dogs, according to a study led by researchers at Oregon State University – Cascades. In a paper published in Applied Microbiology, the authors report a novel strain of Paenibacillus bacteria with characteristics of a probiotic – an organism that conveys a health benefit to the host. In this case, the benefit would be to head off canine inflammatory ...
Host genetics helps explain childhood cancer survivors’ mortality risk from second cancers
(MEMPHIS, Tenn. – October 02, 2023) The population of childhood cancer survivors in the U.S. is increasing, with an overall childhood cancer survival rate greater than 85% five years after diagnosis. However, survivors can still be at increased risk of various health conditions, including second cancers. Using data from the Childhood Cancer Survivor Study (CCSS) and the St. Jude Lifetime Cohort Study (St. Jude Life), scientists at St. Jude Children’s Research Hospital have identified a genetic ...
LAST 30 PRESS RELEASES:
DNA aptamer drug sensors can instantly detect cocaine, heroin and fentanyl – even when combined with other drugs
New project will use next-gen at-home rapid test to track COVID-19, RSV, and flu
SRI relaunches the PARC Forum event series as it celebrates the first anniversary of acquiring the storied Palo Alto Research Center
An inside look at Beech tree disease
New AI model draws treasure maps to diagnose disease
Breastfeeding after COVID-19 booster can give babies antibodies
Researchers closing in on genetic treatments for hereditary lung disease, vision loss
COVID-19 associated with increased risk for autoimmune inflammatory rheumatic diseases up to a year after infection
UC Irvine receives $15 million NSF grant for integrative movement research
University of Houston engineer Metin Akay featured in study highlighting 50 scientists' contributions to biomedical engineering advancements
JWST captures the end of planet formation
Good news—MS drugs taken while breastfeeding may not affect child development
Programs intended to reduce health insurance premiums may make coverage less affordable for the middle class
PrEP discontinuation in a US national cohort of sexual and gender minority populations, 2017–22
USC Study: Medicare Part D plans increased restrictions on drug coverage
Sacituzumab govitecan plus platinum-based chemotherapy in breast, bladder, and lung carcinomas
Global study unveils "problematic" use of porn
Newly discovered protein prevents DNA triplication
Less ice in the arctic ocean has complex effects on marine ecosystems and ocean productivity
Antarctica’s coasts are becoming less icy
New research shows migrating animals learn by experience
Modeling the origins of life: New evidence for an “RNA World”
Scientists put forth a smarter way to protect a smarter grid
An evolutionary mystery 125 million years in the making
Data science approach to identifying thermal conductivity-related structural factors in amorphous materials
Deciphering the male breast cancer genome
Detection of suicide-related emergencies among children using real-world clinical data: A free webinar from the Brain & Behavior Research Foundation
Editor-in-Chief of Sustainability and Climate Change Madhavi Venkatesan named USA TODAY Woman of the Year for Massachusetts for leading plastic bottle ban efforts
Tests show high-temperature superconducting magnets are ready for fusion
Zika vaccine safe, effective when administered during pregnancy[Press-News.org] Pregnant women offered new hope for safe and effective gestational diabetes treatment
New study from University of Galway alleviates concerns over metformin drug for mothers and babies